Glutathione Transferases: Potential Targets to Overcome Chemoresistance in Solid Tumors

Marija Pljesa-Ercegovac1,2, Ana Savic-Radojevic3,4, Marija Matic5,6

  • 1Institute of Medical and Clinical Biochemistry, Faculty of Medicine, University of Belgrade, 11 000 Belgrade, Serbia. m.pljesa.ercegovac@gmail.com.

Insights

Glutathione transferases (GSTs) are key in cancer chemoresistance. Targeting these enzymes with specific inhibitors or pro-drugs offers a promising strategy for novel cancer therapies.

Area of Science:

  • Biochemistry
  • Oncology
  • Pharmacology

Background:

  • Multifunctional enzymes glutathione transferases (GSTs) play a critical role in the development of chemoresistance in cancer.
  • Their polymorphic nature and substrate promiscuity enable detoxification of chemotherapeutics and regulation of cell signaling pathways involved in proliferation and apoptosis.
  • Distinct GST expression profiles across cancer types offer opportunities for targeted therapeutic strategies.

Purpose of the Study:

  • To explore the potential of glutathione transferases (GSTs) as therapeutic targets in cancer treatment.
  • To review the application of GST isoenzyme-specific inhibitors and pro-drugs for selective cancer therapy.
  • To discuss the development of novel GST-targeted drugs for overcoming chemoresistance.

Main Methods:

  • Review of existing literature on glutathione transferases (GSTs) in cancer chemoresistance.
  • Analysis of current clinical trials involving GST inhibitors.
  • Examination of strategies for GST-targeted pro-drug bio-activation and development.

Main Results:

  • Certain GST inhibitors are currently undergoing clinical trials.
  • GST isoenzymes can be utilized for targeted bio-activation of specific pro-drugs, enhancing accumulation in cancer cells.
  • Development of GST pro-drugs, derived from conventional anti-cancer agents, is a novel approach for solid tumor treatment.

Conclusions:

  • Glutathione transferases (GSTs) represent a promising target for novel cancer therapies due to their role in chemoresistance.
  • Targeted inhibition or bio-activation strategies exploiting GST isoenzyme specificity can enhance therapeutic efficacy and reduce side effects.
  • Future drug design should focus on selectively targeting GST-overexpressing cancers to combat chemoresistance and minimize off-target toxicity.

Related Concept Videos

Metallic Solids02:37

Metallic Solids

Metallic solids such as crystals of copper, aluminum, and iron are formed by metal atoms. The structure of metallic crystals is often described as a uniform distribution of atomic nuclei within a “sea” of delocalized electrons. The atoms within such a metallic solid are held together by a unique force known as metallic bonding that gives rise to many useful and varied bulk properties.
All metallic solids exhibit high thermal and electrical conductivity, metallic luster, and malleability....
20.6K
Structures of Solids02:22

Structures of Solids

Solids in which the atoms, ions, or molecules are arranged in a definite repeating pattern are known as crystalline solids. Metals and ionic compounds typically form ordered, crystalline solids. A crystalline solid has a precise melting temperature because each atom or molecule of the same type is held in place with the same forces or energy. Amorphous solids or non-crystalline solids (or, sometimes, glasses) which lack an ordered internal structure and are randomly arranged. Substances that...
17.7K
Network Covalent Solids02:18

Network Covalent Solids

Network covalent solids contain a three-dimensional network of covalently bonded atoms as found in the crystal structures of nonmetals like diamond, graphite, silicon, and some covalent compounds, such as silicon dioxide (sand) and silicon carbide (carborundum, the abrasive on sandpaper). Many minerals have networks of covalent bonds.
To break or to melt a covalent network solid, covalent bonds must be broken. Because covalent bonds are relatively strong, covalent network solids are typically...
16.2K
Molecular and Ionic Solids02:54

Molecular and Ionic Solids

Crystalline solids are divided into four types: molecular, ionic, metallic, and covalent network based on the type of constituent units and their interparticle interactions.
Molecular Solids
Molecular crystalline solids, such as ice, sucrose (table sugar), and iodine, are solids that are composed of neutral molecules as their constituent units. These molecules are held together by weak intermolecular forces such as London dispersion forces, dipole-dipole interactions, or hydrogen bonds, which...
20.1K
Bioavailability Enhancement: Determination and Conceptual Approaches in Overcoming Bioavailability Problems01:22

Bioavailability Enhancement: Determination and Conceptual Approaches in Overcoming Bioavailability Problems

Body:Bioavailability is a critical pharmacological concept that measures the extent and rate at which an active drug ingredient or therapeutic moiety enters the systemic circulation, remaining unchanged. It's a pivotal factor in determining a drug's efficacy and safety.The Biopharmaceutics Classification System (BCS) plays an essential role in drug development by categorizing drugs into four classes based on their solubility and permeability. This classification aids in understanding drug...
212
Phase II Reactions: Glutathione Conjugation and Mercapturic Acid Formation01:22

Phase II Reactions: Glutathione Conjugation and Mercapturic Acid Formation

Glutathione, a tripeptide made up of glutamate, cysteine, and glycine, is a critical player in the detoxification of drugs and xenobiotics via a process known as glutathione conjugation or mercapturic acid formation. This phase II biotransformation reaction involves the covalent binding of glutathione to a drug or its metabolite, enhancing the compound's water solubility and enabling its excretion.
Several distinctive characteristics distinguish glutathione conjugation from other phase II...
928